RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More information1st July 2026
Summary: At its meeting from 16th to 18th June 2026, the CVMP adopted opinions on veterinary medicinal products, including recommendations relating to new marketing authorisations and variations to existing products. The committee also considered scientific, regulatory and safety matters affecting veterinary medicines across the European Union, supporting the availability of safe, effective and high-quality treatments for animal health. The meeting highlights provide an overview of the committee's latest decisions and ongoing work to strengthen veterinary medicines regulation.